Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | February 26, 2007 | February 28, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 26, 2007 · Filed February 28, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares without par valueSEC Table I · non-derivative | Direct | 120,427 |
Ending reported balance
After 2007-02-26 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2007-02-26 · Exercise / conversion · Acquired 1,954 · Balance 118,553 Row 2 · 2007-02-26 · Exercise / conversion · Acquired 1,393 · Balance 119,946 Row 3 · 2007-02-26 · Exercise / conversion · Acquired 14,515 · Balance 134,461 Row 4 · 2007-02-26 · Tax withholding · Disposed 14,034 · Balance 120,427 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.77 · Expires 2008-02-12 | Direct | 0 |
Reported balance
After 2007-02-26 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2007-02-26 · Exercise / conversion · Disposed 1,954 · Balance 0 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.23 · Expires 2013-02-13 | Direct | 0 |
Reported balance
After 2007-02-26 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2007-02-26 · Exercise / conversion · Disposed 1,393 · Balance 0 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.40 · Expires 2012-06-27 | Direct | 6,234 |
Reported balance
After 2007-02-26 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2007-02-26 · Exercise / conversion · Disposed 14,515 · Balance 6,234 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.59 · Expires 2008-02-12 | Direct | 1,267 |
Reported balance
After 2007-02-26 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2007-02-26 · Grant · Acquired 1,267 · Balance 1,267 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.59 · Expires 2013-02-13 | Direct | 1,072 |
Reported balance
After 2007-02-26 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2007-02-26 · Grant · Acquired 1,072 · Balance 1,072 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.59 · Expires 2012-06-27 | Direct | 11,695 |
Reported balance
After 2007-02-26 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2007-02-26 · Grant · Acquired 11,695 · Balance 11,695 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 11,178 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 11,178 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2007. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 357 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 357 F2: Reporting person disclaims beneficial ownership of all securities held by his sons. F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 300 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 300 F2: Reporting person disclaims beneficial ownership of all securities held by his sons. F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 293 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 293 F2: Reporting person disclaims beneficial ownership of all securities held by his sons. F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2007.
F2: Reporting person disclaims beneficial ownership of all securities held by his sons.
F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2005 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,973 Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 9,162 | $0.00 Strike: $49.02 | $0.00 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,162 Underlying: common shares · 9,162 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 11,381 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,583 Underlying: common shares · 11,381 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,162 | $49.02 | $449,121.24 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,723 Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 11,381 | $33.23 | $378,206.56 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 4,623 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,623 Underlying: common shares · 4,623 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,597 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,964 Underlying: common shares · 5,597 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,623 | $46.65 | $215,662.95 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,504 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,597 | $33.23 | $185,996.15 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008018 · a4.xml · derivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F5 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07, and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008018 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,530 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| January 21, 2005 Filed Jan 25, 2005 18:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,728 | $45.85 | $400,157.85 |
DisclosureSEC source: 0001104659-05-002467 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,230 Read SEC document |
| December 16, 2004 Filed Jan 25, 2005 18:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002467 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,958 Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 3,971 | $0.00 Strike: $44.96 | $0.00 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · derivative · entry 12 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,971 Underlying: Common Shares · 3,971 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,830 | $0.00 Strike: $44.96 | $0.00 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · derivative · entry 11 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,830 Underlying: Common Shares · 2,830 shares Expires 2006-02-08 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,715 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,561 Underlying: Common Shares · 4,715 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,197 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568 Underlying: Common Shares · 6,197 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 6,801 | $44.96 | $305,772.96 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,567 Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 4,715 | $33.23 | $156,686.05 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 17:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 6,197 | $20.53 | $127,253.54 |
DisclosureSEC source: 0001104659-04-035423 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2004 Filed Apr 22, 2004 19:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 13,684 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001104659-04-010939 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,684 Underlying: common shares · 13,684 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| April 20, 2004 Filed Apr 22, 2004 19:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 15,569 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-010939 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,431 Underlying: common shares · 15,569 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| April 20, 2004 Filed Apr 22, 2004 19:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,684 | $44.20 | $604,832.80 |
DisclosureSEC source: 0001104659-04-010939 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,456 Read SEC document |
| April 20, 2004 Filed Apr 22, 2004 19:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 15,569 | $35.36 | $550,519.84 |
DisclosureSEC source: 0001104659-04-010939 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 55,000 | $0.00 Strike: $43.66 | $0.00 |
DisclosureSEC source: 0001104659-04-005613 · a4.xml · derivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: common shares · 55,000 shares Expires 2014-02-19 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 8,000 | $43.66 | $349,280.00 |
DisclosureSEC source: 0001104659-04-005613 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,571 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 30, 2003 Filed Dec 31, 2003 20:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 3,539 | $0.00 Strike: $47.15 | $0.00 |
DisclosureSEC source: 0001104659-03-029449 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,539 Underlying: common shares · 3,539 shares Expires 2008-02-12 F4 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 30, 2003 Filed Dec 31, 2003 20:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,070 | $0.00 Strike: $37.00 | $0.00 |
DisclosureSEC source: 0001104659-03-029449 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,930 Underlying: common shares · 4,070 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2003 Filed Dec 31, 2003 20:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 861 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-03-029449 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,571 Read SEC document |
| December 30, 2003 Filed Dec 31, 2003 20:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,539 | $47.15 | $166,863.85 |
DisclosureSEC source: 0001104659-03-029449 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,432 Read SEC document |
| December 30, 2003 Filed Dec 31, 2003 20:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,070 | $37.00 | $150,590.00 |
DisclosureSEC source: 0001104659-03-029449 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2003 Filed Oct 2, 2003 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $42.44 | $0.00 |
DisclosureSEC source: 0001104659-03-022125 · a4.xml · derivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: common shares · 20,000 shares Expires 2013-09-30 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 6,667, 6,666 and 6,667 beginning on 10/01/04, the first anniversary date of the grant. Read SEC document |
| October 01, 2003 Filed Oct 2, 2003 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 10,000 | $42.44 | $424,400.00 |
DisclosureSEC source: 0001104659-03-022125 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,901 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.